Cerecor

YTD

ALL

Why Robinhood?

You can watch Cerecor and buy or sell other stocks, ETFs, and their options commission-free!

About CERC

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders.

CEO

Garry Arthur Neil, MD

CEOGarry Arthur Neil, MD

Employees

Employees23

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2011

Founded2011

Employees

Employees23

CERC Key Statistics

Market cap

31.72M

Market cap31.72M

Price-Earnings ratio

-0.19

Price-Earnings ratio-0.19

Dividend yield

—

Dividend yield—

Average volume

78.93K

Average volume78.93K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$16.00

52 Week high$16.00

52 Week low

$3.39

52 Week low$3.39

People also own

Based on the portfolios of people who own CERC. This list is generated using Robinhood data, and it’s not a recommendation.